SynthesisFunction (Oxford, England)2023
A Reappraisal of the Effects of L-type Ca
Synthesis in Function (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- Research progress on the role and mechanism of STIM and Orai protein-mediated store-operated calcium entry in cardiovascular diseases.Channels (Austin, Tex.) · 2026Review
- L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure.Clinical and experimental hypertension (New York, N.Y. : 1993) · 2025Article
- Article
- Amlodipine increases risk of primary open-angle glaucoma.Clinical hypertension · 2024Article
- The Reappraisal of the Reappraisal-CRAC Channels Are Activated by L-Type CaFunction (Oxford, England) · 2024Article
- Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers.Function (Oxford, England) · 2023Article
- How Do We Clean Up the Scientific Record?Function (Oxford, England) · 2023Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
Abstract
Dihydropyridines such as amlodipine are widely used as antihypertensive agents, being prescribed to ∼70 million Americans and >0.4 billion adults worldwide. Dihydropyridines block voltage-gated Ca
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.